The use of balanced HES 130/0.42 during complex cardiac surgery; Effect on blood coagulation and fluid balance: A randomized controlled trial

Perfusion (United Kingdom)

Volumn 30, Issue 3, 2015, Pages 224-232

  Schramko, A ^a   Suojaranta Ylinen, R ^a   Niemi, T ^a   Pesonen, E ^a   Kuitunen, A ^b   Raivio, P ^a   Salmenpera M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

cardiac surgery; colloids; thromboelastometry

Indexed keywords

CREATININE; HETASTARCH DERIVATIVE; HYDROXYETHYL STARCH 130 0.42; RINGER ACETATE; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; HES 130-0.4; ISOTONIC SOLUTION; RINGER'S SOLUTION;

AGED; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHEST TUBE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; FLUID BALANCE; HEMODYNAMICS; HEMOSTASIS; HUMAN; KIDNEY FUNCTION; LUNG EXTRAVASCULAR FLUID; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SYSTEMIC VASCULAR RESISTANCE; THORAX DRAINAGE; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPH; URINE VOLUME; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECTS; ELECTROLYTE BALANCE; MULTICENTER STUDY; POSTOPERATIVE CARE; THROMBOELASTOGRAPHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; MALE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY; WATER-ELECTROLYTE BALANCE;

EID: 84924970825     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659114540022     Document Type: Article

References (24)

1. Tollofsrud S, Svennevig JL, Breivik H, et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand. 39: 671-677
2. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004; 98: 291-297
3. Despotis GJ, Avidan MS, Hogue CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg. 2001; 72: S1821 - S1831
4. Brunkhorst FM, Engel C, Bloos F, et al. German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358: 125-139
5. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 102: 998-1006
6. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products-different effects. Anesthesiology. 2009; 111: 187-202
7. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg. 2007; 94: 427-433
8. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth. 2010; 104: 691-697
9. Sumpelmann R, Kretz FJ, Luntzer R, et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth. 2012; 22: 371-378
10. Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth. 2013; 110: 231-240
11. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012; 367: 124-134
12. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg. 2007; 105: 905-917
13. Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg. 1989; 37: 158-162
14. Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000; 47: 1207-1215
15. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007; 116: 1896-1906
16. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008; 109: 723-740
17. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Eng J Med. 2012; 367: 1901-1911
18. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. Crit Care. 2005; 9: R687 - R693
19. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesthesia & Analgesia. 2011; 112: 635-645
20. Verheij J, van Lingen A, Raijmakers PG, et al. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Br J Anaesth. 2006; 96: 21-30
21. Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth. 2008; 100: 504-508
22. Gurbuz H, Durukan A, Salman N, et al. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg. 2013; 8: 71
23. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007; 116: 2544-2552
24. Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothor Vasc An. 2012; 26: 64-69